Notice of Annual General Meeting
Avecho Biotechnology will hold its Annual General Meeting on the 13th July, 2020. The AGM will be held in virtual form, and shareholders are invited to register via the provided Webinar Registration Platform below.
Virtual AGM registration
Register for Avecho Biotechnology’s Annual General Meeting.
Delivering more for our investors.
Welcome to our Investor Centre. Here you’ll find information about our business, from presentation and analyst reports, ASX announcements, stock information distribution and tax.
ASX
- Loading stock data...
Investor highlights
Offices: Melbourne (Australia)
ASX: AVE (previously traded as Phosphagenics, POH)
TPM® products commercialised under license;
- Voveran® TPM Gel; Novartis, India
- Instanac® TPM Gel; Themis Medicare
- Vital ET® Biofunctional Ingredient; Ashland
- TPM® (for personal care only); Ashland
Investor Resources
Investor Presentations
| Phosphagenics Investor Fact Sheet | 542 KB | |
| Analyst Report NDF Research | 768 KB | |
| Phosphagenics Investor Presentation | 1 MB |
Governance
| Anti-Bribery & Corruption Policy | 195 KB | |
| Securities Trading Policy | 164 KB | |
| Remuneration and Nomination Committee Charter | 206 KB | |
| Audit & Risk Committee Charter | 163 KB | |
| Shareholder Communication Policy | 151 KB | |
| Privacy Policy | 178 KB | |
| Diversity Policy | 156 KB | |
| Continuous Disclosure Policy | 187 KB | |
| Code of Conduct | 179 KB | |
| Board Charter | 211 KB | |
| Whistleblower Policy | 266 KB | |
| Appendix 4G and Corporate Governance Statement | 423 KB |